[Federal Register Volume 76, Number 125 (Wednesday, June 29, 2011)]
[Notices]
[Page 38122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-16258]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning the 2-
Guanidino-4-oxo-Imidazoline Derivatives as Antimalarial Agents, 
Synthesis of and Methods of Use Thereof

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/518,800, entitled ``2-Guanidino-4-oxo-Imidazoline Derivatives as 
Antimalarial Agents, Synthesis and Methods of Use Thereof,'' filed on 
April 26, 2011. The United States Government, as represented by the 
Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
Attn: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to new 2-guanidino-4-
oxo-imidazoline derivatives (deoxo-IZ), methods of making these 
compounds, compositions containing the same, and methods of using the 
same to prevent, treat, or inhibit malaria in a subject. The compounds 
have radical curative antimalarial activity.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-16258 Filed 6-28-11; 8:45 am]
BILLING CODE 3710-08-P